Uric acid and the development of hypertension

Medical Science Monitor

Volumn 16, Issue 10, 2010, Pages

  Hwu, Chii Min ^a,b   Lin, Kuan Hung ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Blood pressure; Hypertension; Hyperuricemia; Uric acid

Indexed keywords

ALLOPURINOL; BENZIODARONE; FEBUXOSTAT; LOSARTAN; PLACEBO; URIC ACID; ATENOLOL;

DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; HYPERURICEMIA; INSULIN RESISTANCE; KIDNEY INJURY; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PEER REVIEW; RENOVASCULAR DISEASE; REVIEW; SYMPATHETIC TONE; URIC ACID BLOOD LEVEL; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CAUSAL ATTRIBUTION; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DISEASE COURSE; DRUG RESPONSE; INFLAMMATORY DISEASE; LONGITUDINAL STUDY; ANIMAL; BLOOD; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; VASCULAR DISEASE;

ANIMALS; CROSS-SECTIONAL STUDIES; HUMANS; HYPERTENSION; HYPERURICEMIA; INSULIN RESISTANCE; KIDNEY; RETROSPECTIVE STUDIES; RISK FACTORS; URIC ACID; VASCULAR DISEASES;

EID: 78049267759     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Watanabe S, Kang DH, Feng L et al: Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension, 2002; 40: 355-360
2. Feig DI, Kang DH, Johnson RJ: Uric acid and cardiovascular risk. N Engl J Med, 2008; 359: 1811-1821
3. Feig DI, John RJ: Hyperuricemia in childhood primary hypertension. Hypertension, 2003; 42: 247-252
4. Syamala S, Li J, Shankar A: Association between serum uric acid and prehypertension among US adults. J Hypertens, 2007; 25: 1583-1589
5. Liang J, Xue Y, Zou C et al: Serum uric acid and prehypertension among Chinese adults. J Hypertens, 2009; 27: 1761-1765
6. Fang J, Alderman MH: Serum uric acid and cardiovascular mortality. The NHANES I Epidemiologic Follow-up Study, 1971-1992. JAMA, 2000; 283: 2404-2410
7. Verdecchia P, Schillaci G, Reboldi G et al: Relation between serum uric acid and risk of cardiovascular diseae in essential hypertension. The PIUMA Study. Hypertension, 2000; 36: 1072-1078
8. Jones DP, Richey PA, Alpert BS, Li R: Serum uric acid and ambulatory blood pressure in children with primary hypertension. Pediatr Res, 2008; 556-561
9. Kahn HA, Medalie JH, Neufeld HN et al: The incidence of hypertension and associated factors: The Israel ischemic heart disease study. Am Heart J, 1972; 84: 171-182
10. Selby JV, Friedman GD, Quesenberry CP: Precursors of essential hypertension: Pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol, 1990; 131: 1017-1027
11. Hunt SC, Stephenson SH, Hopkins PN, Williams RR: Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension, 1991; 17: 969-976
12. Jossa F, Farinaro F, Panico S et al: Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens, 1994; 8: 677-681
13. Dyer AR, Liu K, Walsh M et al: Ten-year incidence of elevated blood pressure and its predictors: The CARDIA Study. J Hum Hypertens, 1999; 13: 13-21
14. Taniguchi Y, Hayashi T, Tsumura K et al: Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: The Osaka Health Survey. J Hypertens, 2001; 19: 1209-1215
15. Masuo K, Kawaguchi H, Mikami H et al: Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension, 2003; 42: 474-80
16. Nakanishi N, Okamoto M, Yoshida H et al: Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol, 2003; 18: 523-530
17. Nagahama K, Inoue T, Iseki K et al: Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res, 2004; 27: 835-841
18. Alper AB Jr, Chen W, Yau L et al: Childhood uric acid predicts adult blood pressure. The Bogalusa Heart Study. Hypertension, 2005; 45: 34-38
19. Sundström J, Sullivan L, D'Agostino RB et al: Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension, 2005; 45: 28-33
20. Mellen PB, Bleyer AJ, Erlinger TP et al: Serum uric acid predicts incident hypertension in a biethnic cohort. The Atherosclerosis Risk in Communities Study. Hypertension, 2006; 48: 1037-1042
21. Perlstein TS, Gumieniak O, Williams GH et al: Uric acid and the development of hypertension. The Normative Aging Study. Hypertension, 2006; 48: 1031-1036
22. Shankar A, Klein R, Klein BEK, Nieto FJ: The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens, 2006; 20: 937-945
23. Forman JP, Choi H, Curhan GC: Plasma uric acid level and risk for in- cident hypertension among men. J Am Soc Nephrol, 2007; 18: 287-292
24. Krishnan E, Kwoh KC, Schumacher HR, Kuller L: Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension, 2007; 49: 298-303
25. Forman JP, Choi H, Curhan GC: Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med, 2009; 169: 155-162
26. Kang DH, Han L, Ouyang X et al: Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol, 2005; 25: 425-433
27. Price KL, Sautin YY, Long DA et al: Human vascular smooth muscles express a urate transporter. J Am Soc Nephrol, 2006; 17: 1791-1795
28. Rao GN, Corson MA, Berk BC: Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor Achain expression. J Biol Chem, 1991; 266: 8604-8608
29. Kanellis J, Watanabe S, Li JH et al: Uric acid stimulates monocyte che- moattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension, 2003; 41: 1287-1293
30. Mazzali M, Kanellis J, Han L et al: Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol, 2002; 282: F991-F997
31. Menè P, Punzo G: Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens, 2008; 26: 2085-2092
32. Johnson RJ, Rodríguez-Iturbe B, Schreiner GF, Herrera-Acosta J: Hypertension: a microvascular and tubulointerstitial disease. J Hypertens, 2002; 20(Suppl.3): S1-S7
33. Han HJ, Lim MJ, Lee YJ et al: Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kB. Am J Physiol Renal Physiol, 2007; 292: F373-F381
34. Kang DH, Nakagawa T, Feng L et al: A role for uric acid in the progres- sion of renal disease. J Am Soc Nephrol, 2002; 13: 2888-2897
35. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodríguez-Iturbe B: Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med, 2002; 346: 913-923
36. Corry DB, Eslami P, Yamamoto K et al: Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens, 2008; 26: 269-275
37. Kang DH, Nakagawa T: Uric acid and chronic renal disease: Possible implication of hyperuricemia on progression of renal disease. Semin Nephrol, 2005; 25: 43-49
38. Sánchez-Lozada LG, Nakagawa T, Kang DH et al: Hormonal and cytokine effects of uric acid. Curr Opin Nephrol Hypertens, 2006; 15: 30-33
39. Khosla UM, Zharikov S, Finch JL et al: Hyperuricemia induces endo thelial dysfunction. Kidney Int, 2005: 67: 1739-1742
40. Kang DH, Park SK, Lee IK, Johnson RJ: Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol, 2005; 16: 3553-3562
41. Mazzali M, Hughes J, Kim JG et al: Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension, 2001; 38: 1101-1106
42. Mercuro G, Vitale C, Cerquetani E et al: Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cadiol, 2004; 94: 932-935
43. Zoccali C, Maio R, Mallamaci F et al: Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol, 2006; 17: 1466-1471
44. Ruggiero C, Cherubini A, Miller E et al: Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am J Cardiol, 2007; 100: 115-121
45. Vekic J, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V et al: High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles. Atherosclerosis, 2009; 203: 236-242
46. Sesso HD, Buring JE, Rifai N et al: C-reactive protein and the risk of developing hypertension. JAMA, 2003; 290: 2945-2951
47. Reaven GM, Litiieli H, Landsberg L: Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system. N Engl J Med, 1996; 334: 374-381
48. Bonora E, Kiechl S, Willeit J et al: Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes, 1998; 47: 1643-1649
49. Vuorinen-Markkola H, Yki-Järvinen H: Hyperuricemia and insulin resistance. J Clin Endocriol Metab, 1994; 78: 25-29
50. Quiñones Galvan A, Natali A, Baldi S et al: Effect of insulin on uric acid excretion in humans. Am J Physiol, 1995; 268: E1-E5
51. Bonora E, Capaldo B, Perin PC et al: Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis, 2008; 18: 624-631
52. Sánchez-Lozada LG, Tapia E, Soto V et al: Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricemia. Nephrol Dial Transplant, 2008; 23: 1179-1185
53. Feig DI, Soletsky B, Johnson RJ: Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension. A randomized trial. JAMA, 2008; 300: 924-932
54. Høieggen A, Alderman MH, Ejeldsen SE et al: The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int, 2004; 65: 1041-1049